Most lately, it's been discovered that conolidine and the above derivatives act to the atypical chemokine receptor 3 (ACKR3. Expressed in equivalent locations as classical opioid receptors, it binds to a big range of endogenous opioids. Unlike most opioid receptors, this receptor acts as a scavenger and won't activate https://carlk753kmn4.blogdun.com/profile